Trial Profile
A double blind, randomized, parallel, cross-over comparision of glycemic control achieved with once a day insulin glargine versus detemir in type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Dec 2010
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 07 Sep 2008 Results presented at the 44th Annual Meeting of the European Association for the Study of Diabetes
- 08 Jun 2008 Status changed from recruiting to completed according to Novo Nordisk.
- 08 Jun 2008 Results were presented at the American Diabetes Association's 68th Annual Scientific Sessions (ADA).